<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-id journal-id-type="hwp">hmg</journal-id>
<journal-title-group>
<journal-title>Human Molecular Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26936825</article-id>
<article-id pub-id-type="pmc">5062590</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddw077</article-id>
<article-id pub-id-type="publisher-id">ddw077</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>ARL3 regulates trafficking of prenylated phototransduction proteins to the rod outer segment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wright</surname>
<given-names>Zachary C.</given-names>
</name>
<xref ref-type="aff" rid="af1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Singh</surname>
<given-names>Ratnesh K.</given-names>
</name>
<xref ref-type="aff" rid="af1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alpino</surname>
<given-names>Ryan</given-names>
</name>
<xref ref-type="aff" rid="af1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Goldberg</surname>
<given-names>Andrew F.X.</given-names>
</name>
<xref ref-type="aff" rid="af4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sokolov</surname>
<given-names>Maxim</given-names>
</name>
<xref ref-type="aff" rid="af1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="af2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="af3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ramamurthy</surname>
<given-names>Visvanathan</given-names>
</name>
<xref ref-type="aff" rid="af1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="af2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="af3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff id="af1"><sup>1</sup>Department of Ophthalmology,</aff>
<aff id="af2"><sup>2</sup>Department of Biochemistry and</aff>
<aff id="af3"><sup>3</sup>Center for Neuroscience, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, WA 26506, USA and</aff>
<aff id="af4"><sup>4</sup>Eye Research Institute, Oakland University, Rochester, MI 48309, USA</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">*To whom correspondence should be addressed at: West Virginia University Eye Institute, One Medical Drive, E-363, Morgantown, WV 26506-9193, USA. Tel: +<phone>1 3045986940</phone>; Fax: +<fax>1 3045986928</fax>; Email: <email>ramamurthyv@wvumedicine.org</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>15</day>
<month>5</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>02</day>
<month>3</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>15</day>
<month>5</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>25</volume>
<issue>10</issue>
<fpage>2031</fpage>
<lpage>2044</lpage>
<history>
<date date-type="received">
<day>11</day>
<month>12</month>
<year>2015</year>
</date>
<date date-type="rev-recd">
<day>1</day>
<month>2</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>2</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="ddw077.pdf"></self-uri>
<abstract>
<p>The small GTPase, ADP-ribosylation factor-like 3 (ARL3), has been proposed to participate in the transport of proteins in photoreceptor cells. Moreover, it has been implicated in the pathogenesis associated with X-linked retinitis pigmentosa (XLRP) resulting from mutations in the ARL3 GTPase activating protein, retinitis pigmentosa 2 (RP2). To determine the importance of ARL3 in rod photoreceptor cells, we generated transgenic mice expressing a dominant active form of ARL3 (ARL3-Q71L) under a rod-specific promoter. ARL3-Q71L animals exhibited extensive rod cell death after post-natal day 30 (PN30) and degeneration was complete by PN70. Prior to the onset of cell death, rod photoresponse was significantly reduced along with a robust decrease in rod phosphodiesterase 6 (PDE6) and G-protein receptor kinase-1 (GRK1) levels. Furthermore, assembled phosphodiesterase-6 (PDE6) subunits, rod transducin and G-protein receptor kinase-1 (GRK1) accumulated on large punctate structures within the inner segment in ARL3-Q71L retina. Defective trafficking of prenylated proteins is likely due to sequestration of prenyl binding protein δ (PrBPδ) by ARL3-Q71L as we demonstrate a specific interaction between these proteins in the retina. Unexpectedly, our studies also revealed a novel role for ARL3 in the migration of photoreceptor nuclei. In conclusion, this study identifies ARL3 as a key player in prenylated protein trafficking in rod photoreceptor cells and establishes the potential role for ARL3 dysregulation in the pathogenesis of RP2-related forms of XLRP.</p>
</abstract>
<funding-group>
<award-group id="funding-1">
<funding-source>National Institutes of Health <named-content content-type="funder-id">http://dx.doi.org/10.13039/100000002</named-content></funding-source>
<award-id>EY017035</award-id>
<award-id>EY019665</award-id>
<award-id>R01EY013246</award-id>
<award-id>RR017890</award-id>
</award-group>
<award-group id="funding-2">
<funding-source>West Virginia Lions</funding-source>
</award-group>
<award-group id="funding-3">
<funding-source>Lions Club International Fund</funding-source>
</award-group>
<award-group id="funding-4">
<funding-source>Research to Prevent Blindness <named-content content-type="funder-id">http://dx.doi.org/10.13039/100001818</named-content></funding-source>
</award-group>
</funding-group>
<counts>
<page-count count="14"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>